A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Allergan

Status and phase: Completed; Phase 3

Conditions: Hyperhidrosis

Treatments: Drug: Botulinum Toxin Type A

Study type: Interventional

Funder types: Industry

Identifiers

NCT00168402

191622-046

Details and patient eligibility

About

This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

Enrollment: 193 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Marked axillary hyperhidrosis

Exclusion criteria

• Previous use of botulinum toxin for hyperhidrosis

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)